FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Breakthrough Status for Knee Implant

FDA grants ZKR Orthopedics a breakthrough device designation for its Lift implant technology, which is designed to delay or eliminate the need for kne...

latest-news-card-1
Federal Register

11 Dr. Reddys ANDAs Withdrawn

Federal Register notice: FDA withdraws 11 ANDAs from Dr. Reddys Laboratories after the company requested the actions because the products are no longe...

Medical Devices

HistoSonics De Novo for Tumor Blaster

FDA grants HistoSonics a de novo marketing authorization for the Edison System, which the company says uses focused sound energy to mechanically destr...

latest-news-card-1
Human Drugs

AstraZeneca Seeks More Input on Study Diversity

AstraZeneca urges FDA to provide more detailed guidance or recommendations on how early in the drug development process sponsors should start to colle...

latest-news-card-1
Human Drugs

Sun Pharma NDA for Alopecia Areata

FDA accepts for review a Sun Pharmaceutical Industries NDA for deuruxolitinib, an investigational oral selective inhibitor of Janus kinases JAK1 and J...

latest-news-card-1
Federal Register

2 Covid-19 Product EUAs Revoked

Federal Register notice: FDA announces the revocation of two Monkeypox-related Emergency Use Authorizations after the authorization holders requested ...

latest-news-card-1
Federal Register

Notice on Info Technology Plan Corrected

Federal Register notice: FDA corrects a 9/19 notice entitled Food and Drug Administration Information Technology Strategy; Request for Comments.

latest-news-card-1
Human Drugs

Novartis Gains Approval of IV Cosentyx

FDA approves Novartis intravenous Cosentyx (secukinumab) formulation for treating adults with psoriatic arthritis, ankylosing spondylitis and non-radi...

latest-news-card-1
Medical Devices

Senator Urges Justice Probe of Respironics

Sen. Richard Blumenthal (D-CT) calls on the Justice Department to take action against Philips Respironics after a recent investigation by ProPublica a...

latest-news-card-1
Human Drugs

FDA OKs Zoryve Cream Expanded Use

FDA approves an Arcutis Biotherapeutics supplemental NDA to expand the indication for Zoryve (roflumilast) cream 0.3% for the topical treatment of pla...